PL
This biotech startup utilizes machine learning and artificial intelligence to enhance pathology image analysis for the early detection of nasopharyngeal cancer. By providing scalable technology, the company enables healthcare professionals to identify this cancer type more accurately and efficiently, improving patient outcomes.
Updated 3 months ago
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This biotech startup utilizes machine learning and artificial intelligence to enhance pathology image analysis for the early detection of nasopharyngeal cancer. By providing scalable technology, the company enables healthcare professionals to identify this cancer type more accurately and efficiently, improving patient outcomes.